Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 704

1.

Molecular Imaging of the Tumor Microenvironment reveals the Relationship between Tumor Oxygenation, Glucose Uptake and Glycolysis in Pancreatic Ductal Adenocarcinoma.

Yamamoto K, Brender JR, Seki T, Kishimoto S, Oshima N, Choudhuri R, Adler SS, Jagoda E, Saito K, Devasahayam N, Choyke PL, Mitchell JB, Krishna MC.

Cancer Res. 2020 Apr 3. pii: canres.0928.2019. doi: 10.1158/0008-5472.CAN-19-0928. [Epub ahead of print]

PMID:
32245793
2.

Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment.

Jadvar H, Ballas LK, Choyke PL, Fanti S, Gulley JL, Herrmann K, Hope TA, Klitzke AK, Oldan JD, Pomper MG, Rowe SP, Subramaniam RM, Taneja SS, Vargas HA, Ahuja S.

J Nucl Med. 2020 Apr;61(4):552-562. doi: 10.2967/jnumed.119.240929. No abstract available.

PMID:
32238495
3.

Mutation Profiles of Urothelial Cancer: Will Genomics Change Radiology or Vice Versa?

Choyke PL.

Radiology. 2020 Mar 31:200583. doi: 10.1148/radiol.2020200583. [Epub ahead of print] No abstract available.

PMID:
32233919
4.

Impact of bowel preparation with Fleet's™ enema on prostate MRI quality.

Coskun M, Mehralivand S, Shih JH, Merino MJ, Wood BJ, Pinto PA, Barrett T, Choyke PL, Turkbey B.

Abdom Radiol (NY). 2020 Mar 25. doi: 10.1007/s00261-020-02487-6. [Epub ahead of print]

PMID:
32211948
5.

Spatial density and diversity of architectural histology in prostate cancer: influence on diffusion weighted magnetic resonance imaging.

Harmon SA, Brown GT, Sanford T, Mehralivand S, Shih JH, Xu S, Merino MJ, Choyke PL, Pinto PA, Wood BJ, McKenney JK, Turkbey B.

Quant Imaging Med Surg. 2020 Feb;10(2):326-339. doi: 10.21037/qims.2020.01.06.

6.

Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?

Sackett J, Shih JH, Reese SE, Brender JR, Harmon SA, Barrett T, Coskun M, Madariaga M, Marko J, Law YM, Turkbey EB, Mehralivand S, Sanford T, Lay N, Pinto PA, Wood BJ, Choyke PL, Turkbey B.

Acad Radiol. 2020 Mar 3. pii: S1076-6332(20)30080-5. doi: 10.1016/j.acra.2020.01.031. [Epub ahead of print]

PMID:
32143993
7.

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.

Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, Bloom J, Gurram S, Siddiqui M, Pinsky P, Parnes H, Linehan WM, Merino M, Choyke PL, Shih JH, Turkbey B, Wood BJ, Pinto PA.

N Engl J Med. 2020 Mar 5;382(10):917-928. doi: 10.1056/NEJMoa1910038.

PMID:
32130814
8.

Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents.

Roy J, Warner BM, Basuli F, Zhang X, Wong K, Pranzatelli T, Ton AT, Chiorini JA, Choyke PL, Lin FI, Jagoda EM.

Cancer Biother Radiopharm. 2020 Feb 19. doi: 10.1089/cbr.2019.3079. [Epub ahead of print]

PMID:
32074455
9.

The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract - first clinical experience.

Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, Rathke H, Winter E, Lindner T, Syed M, Bhatti IA, Herfarth K, Choyke PL, Jaeger D, Haberkorn U, Debus J, Giesel FL.

J Nucl Med. 2020 Feb 14. pii: jnumed.119.237016. doi: 10.2967/jnumed.119.237016. [Epub ahead of print]

PMID:
32060216
10.

A case report of multiple primary prostate tumors with differential drug sensitivity.

Wilkinson S, Harmon SA, Terrigino NT, Karzai F, Pinto PA, Madan RA, VanderWeele DJ, Lake R, Atway R, Bright JR, Carrabba NV, Trostel SY, Lis RT, Chun G, Gulley JL, Merino MJ, Choyke PL, Ye H, Dahut WL, Turkbey B, Sowalsky AG.

Nat Commun. 2020 Feb 13;11(1):837. doi: 10.1038/s41467-020-14657-7.

11.

Positron emission tomography (PET) radiotracers for prostate cancer imaging.

Walker SM, Lim I, Lindenberg L, Mena E, Choyke PL, Turkbey B.

Abdom Radiol (NY). 2020 Feb 11. doi: 10.1007/s00261-020-02427-4. [Epub ahead of print] Review.

PMID:
32047993
12.

In-vivo tracking of adoptively transferred natural killer-cells in rhesus macaques using 89Zirconium-oxine cell labeling and PET imaging.

Sato N, Stringaris K, Davidson-Moncada JK, Reger R, Adler SS, Dunbar C, Choyke PL, Childs RW.

Clin Cancer Res. 2020 Feb 7. pii: clincanres.2897.2019. doi: 10.1158/1078-0432.CCR-19-2897. [Epub ahead of print]

PMID:
32034075
13.

Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.

Maruoka Y, Furusawa A, Okada R, Inagaki F, Fujimura D, Wakiyama H, Kato T, Nagaya T, Choyke PL, Kobayashi H.

Cancer Immunol Res. 2020 Mar;8(3):345-355. doi: 10.1158/2326-6066.CIR-19-0517. Epub 2020 Jan 17.

PMID:
31953245
14.

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.

Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA.

J Clin Oncol. 2020 Jan 15:JCO1902757. doi: 10.1200/JCO.19.02757. [Epub ahead of print]

PMID:
31940221
15.

Rapid perceptual processing in two- and three-dimensional prostate images.

Treviño M, Turkbey B, Wood BJ, Pinto PA, Czarniecki M, Choyke PL, Horowitz TS.

J Med Imaging (Bellingham). 2020 Mar;7(2):022406. doi: 10.1117/1.JMI.7.2.022406. Epub 2020 Jan 3.

PMID:
31930156
16.

Discussions with Leaders: A Conversation Between Martin Pomper and Peter Choyke.

Pomper MG, Choyke PL.

J Nucl Med. 2020 Jan;61(1):3-5. doi: 10.2967/jnumed.119.240390. No abstract available.

PMID:
31896725
17.

18F-fluciclovine PET or PSMA PET for prostate cancer imaging?

Turkbey B, Choyke PL.

Nat Rev Urol. 2020 Jan;17(1):9-10. doi: 10.1038/s41585-019-0255-6. No abstract available.

PMID:
31676885
18.

18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy.

Mena E, Lindenberg ML, Turkbey IB, Shih JH, Harmon SA, Lim I, Lin FI, Adler S, Eclarinal P, McKinney Y, Citrin D, Dahut W, Wood B, Krishnasamy V, Chang R, Levy E, Merino M, Pinto P, Eary JF, Choyke PL.

J Nucl Med. 2019 Nov 1. pii: jnumed.119.234799. doi: 10.2967/jnumed.119.234799. [Epub ahead of print]

PMID:
31676732
19.

Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.

Turkbey B, Czarniecki M, Shih JH, Harmon SA, Agarwal PK, Apolo AB, Citrin DE, Gulley JL, Harisinghani M, Madan RA, Metwalli AR, Paquette E, Pinto PA, Rais-Bahrami S, Rowe LS, Wood BJ, Jacobs PM, Lindenberg L, Dahut W, Choyke PL.

AJR Am J Roentgenol. 2020 Jan;214(1):105-113. doi: 10.2214/AJR.19.21264. Epub 2019 Oct 15.

PMID:
31613660
20.

Erratum: Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks system (Erratum).

Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM.

J Med Imaging (Bellingham). 2019 Jul;6(3):039803. doi: 10.1117/1.JMI.6.3.039803. Epub 2019 Sep 27.

21.

Prostate specific membrane antigen (PSMA) imaging: the past is prologue.

Choyke PL, Bouchelouche K.

Transl Androl Urol. 2019 Aug;8(4):283-285. doi: 10.21037/tau.2019.07.20. No abstract available.

22.

Near-infrared photoimmunotherapy through bone.

Nakamura YA, Okuyama S, Furusawa A, Nagaya T, Fujimura D, Okada R, Maruoka Y, Eclarinal PC, Choyke PL, Kobayashi H.

Cancer Sci. 2019 Dec;110(12):3689-3694. doi: 10.1111/cas.14203. Epub 2019 Oct 22.

23.

18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab.

Lim I, Lindenberg ML, Mena E, Verdini N, Shih JH, Mayfield C, Thompson R, Lin J, Vega A, Mallek M, Cadena J, Diaz C, Mortazavi A, Knopp M, Wright C, Stein M, Pal S, Choyke PL, Apolo AB.

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):178-184. doi: 10.1007/s00259-019-04483-5. Epub 2019 Sep 14.

24.

A multiparametric magnetic resonance imaging-based virtual reality surgical navigation tool for robotic-assisted radical prostatectomy.

Mehralivand S, Kolagunda A, Hammerich K, Sabarwal V, Harmon S, Sanford T, Gold S, Hale G, Romero VV, Bloom J, Merino MJ, Wood BJ, Kambhamettu C, Choyke PL, Pinto PA, Türkbey B.

Turk J Urol. 2019 Sep 1;45(5):357-365. doi: 10.5152/tud.2019.19133. Print 2019 Sep.

25.

The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.

Okada R, Maruoka Y, Furusawa A, Inagaki F, Nagaya T, Fujimura D, Choyke PL, Kobayashi H.

Bioconjug Chem. 2019 Oct 16;30(10):2624-2633. doi: 10.1021/acs.bioconjchem.9b00547. Epub 2019 Sep 23.

PMID:
31498995
26.

Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs).

Kobayashi H, Griffiths GL, Choyke PL.

Bioconjug Chem. 2020 Jan 15;31(1):28-36. doi: 10.1021/acs.bioconjchem.9b00546. Epub 2019 Sep 13.

PMID:
31479610
27.

Apical periurethral transition zone lesions: MRI and histology findings.

Tuncer S, Mehralivand S, Harmon SA, Sanford T, Brown GT, Rowe LS, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Abdom Radiol (NY). 2019 Aug 29. doi: 10.1007/s00261-019-02194-x. [Epub ahead of print]

PMID:
31468153
28.

In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency.

Berman RM, Kelada OJ, Gutsche NT, Natarajan R, Swenson RE, Fu Y, Hong J, Ho M, Choyke PL, Escorcia FE.

Cancer Biother Radiopharm. 2019 Oct;34(8):498-503. doi: 10.1089/cbr.2019.2888. Epub 2019 Aug 19.

29.

Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice.

Kishimoto S, Brender JR, Crooks DR, Matsumoto S, Seki T, Oshima N, Merkle H, Lin P, Reed G, Chen AP, Ardenkjaer-Larsen JH, Munasinghe J, Saito K, Yamamoto K, Choyke PL, Mitchell J, Lane AN, Fan TW, Linehan WM, Krishna MC.

Elife. 2019 Aug 13;8. pii: e46312. doi: 10.7554/eLife.46312.

30.

Near-Infrared Photoimmunotherapy of Cancer.

Kobayashi H, Choyke PL.

Acc Chem Res. 2019 Aug 20;52(8):2332-2339. doi: 10.1021/acs.accounts.9b00273. Epub 2019 Jul 23.

31.

Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic Management.

Koerber SA, Stach G, Kratochwil C, Haefner MF, Rathke H, Herfarth K, Kopka K, Holland-Letz T, Choyke PL, Haberkorn U, Debus J, Giesel FL.

J Nucl Med. 2020 Jan;61(1):46-50. doi: 10.2967/jnumed.119.227637. Epub 2019 Jul 13.

PMID:
31302638
32.

Fluorine-18 Labeled Fluorofuranylnorprogesterone ([18F]FFNP) and Dihydrotestosterone ([18F]FDHT) Prepared by "Fluorination on Sep-Pak" Method.

Basuli F, Zhang X, Blackman B, White ME, Jagoda EM, Choyke PL, Swenson RE.

Molecules. 2019 Jun 28;24(13). pii: E2389. doi: 10.3390/molecules24132389.

33.

PI-RADS version 2.1: one small step for prostate MRI.

Barrett T, Rajesh A, Rosenkrantz AB, Choyke PL, Turkbey B.

Clin Radiol. 2019 Nov;74(11):841-852. doi: 10.1016/j.crad.2019.05.019. Epub 2019 Jun 22. Review.

PMID:
31239107
34.

New Targets for PET Molecular Imaging of Prostate Cancer.

Mena E, Lindenberg LM, Choyke PL.

Semin Nucl Med. 2019 Jul;49(4):326-336. doi: 10.1053/j.semnuclmed.2019.02.001. Epub 2019 Mar 9. Review.

PMID:
31227055
35.

Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate Cancer.

Roth AR, Harmon SA, Perk TG, Eickhoff J, Choyke PL, Kurdziel KA, Dahut WL, Apolo AB, Morris MJ, Perlman SB, Liu G, Jeraj R.

Clin Genitourin Cancer. 2019 Aug;17(4):306-314. doi: 10.1016/j.clgc.2019.05.013. Epub 2019 May 27.

PMID:
31221545
36.

Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance.

Bloom JB, Lebastchi AH, Gold SA, Hale GR, Sanford T, Mehralivand S, Ahdoot M, Rayn KN, Czarniecki M, Smith C, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

BJU Int. 2019 Nov;124(5):768-774. doi: 10.1111/bju.14835. Epub 2019 Jun 26.

PMID:
31141307
37.

Artificial intelligence at the intersection of pathology and radiology in prostate cancer.

Harmon SA, Tuncer S, Sanford T, Choyke PL, Türkbey B.

Diagn Interv Radiol. 2019 May;25(3):183-188. doi: 10.5152/dir.2019.19125. Review.

38.

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.

Jagoda EM, Vasalatiy O, Basuli F, Opina ACL, Williams MR, Wong K, Lane KC, Adler S, Ton AT, Szajek LP, Xu B, Butcher D, Edmondson EF, Swenson RE, Greiner J, Gulley J, Eary J, Choyke PL.

Mol Imaging. 2019 Jan-Dec;18:1536012119829986. doi: 10.1177/1536012119829986.

39.

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.

Gold SA, VanderWeele DJ, Harmon S, Bloom JB, Karzai F, Hale GR, Marhamati S, Rayn KN, Mehralivand S, Merino MJ, Gulley JL, Bilusic M, Madan RA, Choyke PL, Turkbey B, Dahut W, Pinto PA.

Urol Oncol. 2019 Jun;37(6):352.e25-352.e30. doi: 10.1016/j.urolonc.2019.01.012. Epub 2019 Apr 15.

PMID:
31000430
40.

Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

Greer MD, Shih JH, Lay N, Barrett T, Bittencourt L, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 27:1-8. doi: 10.2214/AJR.18.20536. [Epub ahead of print]

PMID:
30917023
41.

First-in-human phase 0 study of 111In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Kurdziel KA, Mena E, McKinney Y, Wong K, Adler S, Sissung T, Lee J, Lipkowitz S, Lindenberg L, Turkbey B, Kummar S, Milenic DE, Doroshow JH, Figg WD, Merino MJ, Paik CH, Brechbiel MW, Choyke PL.

J Transl Sci. 2019 Apr;5(2). doi: 10.15761/JTS.1000269. Epub 2018 Jul 13.

42.

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.

Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC.

Eur Urol. 2019 Sep;76(3):340-351. doi: 10.1016/j.eururo.2019.02.033. Epub 2019 Mar 18. Review.

PMID:
30898406
43.

Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better?

Sackett J, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 19:1-9. doi: 10.2214/AJR.19.21178. [Epub ahead of print]

PMID:
30888865
44.

Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks.

Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM.

J Med Imaging (Bellingham). 2018 Oct;5(4):044507. doi: 10.1117/1.JMI.5.4.044507. Epub 2018 Dec 15. Erratum in: J Med Imaging (Bellingham). 2019 Jul;6(3):039803.

45.

Novel Imaging in Detection of Metastatic Prostate Cancer.

Smith CP, Laucis A, Harmon S, Mena E, Lindenberg L, Choyke PL, Turkbey B.

Curr Oncol Rep. 2019 Mar 5;21(4):31. doi: 10.1007/s11912-019-0780-8. Review.

PMID:
30834999
46.

Dynamic Imaging of Glucose and Lactate Metabolism by 13C-MRS without Hyperpolarization.

Brender JR, Kishimoto S, Merkle H, Reed G, Hurd RE, Chen AP, Ardenkjaer-Larsen JH, Munasinghe J, Saito K, Seki T, Oshima N, Yamamoto K, Choyke PL, Mitchell J, Krishna MC.

Sci Rep. 2019 Mar 4;9(1):3410. doi: 10.1038/s41598-019-38981-1.

47.

The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy.

Roy J, Kuo F, Basuli F, Williams MR, Wong K, Green MV, Seidel J, Adler SS, Xu B, Choyke PL, Jagoda EM.

Cancer Biother Radiopharm. 2019 May;34(4):238-244. doi: 10.1089/cbr.2018.2656. Epub 2019 Feb 15.

PMID:
30767667
48.

Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).

Siddiqui MR, Railkar R, Sanford T, Crooks DR, Eckhaus MA, Haines D, Choyke PL, Kobayashi H, Agarwal PK.

Sci Rep. 2019 Feb 14;9(1):2084. doi: 10.1038/s41598-019-38575-x.

49.

PET imaging in renal cancer.

Lindenberg L, Mena E, Choyke PL, Bouchelouche K.

Curr Opin Oncol. 2019 May;31(3):216-221. doi: 10.1097/CCO.0000000000000518. Review.

PMID:
30747736
50.

A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion.

Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL.

Oncotarget. 2018 Dec 28;9(102):37676-37688. doi: 10.18632/oncotarget.26481. eCollection 2018 Dec 28.

Supplemental Content

Loading ...
Support Center